Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

A unique variant of lymphocytic choriomeningitis virus that induces pheromone binding protein MUP: Critical role for CTL.

Ware BC, Sullivan BM, LaVergne S, Marro BS, Egashira T, Campbell KP, Elder J, Oldstone MBA.

Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):18001-18008. doi: 10.1073/pnas.1907070116. Epub 2019 Aug 19.

PMID:
31427525
2.

Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics.

Oldstone MBA, Ware BC, Horton LE, Welch MJ, Aiolfi R, Zarpellon A, Ruggeri ZM, Sullivan BM.

Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7814-E7823. doi: 10.1073/pnas.1804674115. Epub 2018 Jul 30.

3.

Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa.

Sakabe S, Sullivan BM, Hartnett JN, Robles-Sikisaka R, Gangavarapu K, Cubitt B, Ware BC, Kotliar D, Branco LM, Goba A, Momoh M, Sandi JD, Kanneh L, Grant DS, Garry RF, Andersen KG, de la Torre JC, Sabeti PC, Schieffelin JS, Oldstone MBA.

Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):E7578-E7586. doi: 10.1073/pnas.1806200115. Epub 2018 Jul 23.

4.

An Outbreak of Ebola Virus Disease in the Lassa Fever Zone.

Goba A, Khan SH, Fonnie M, Fullah M, Moigboi A, Kovoma A, Sinnah V, Yoko N, Rogers H, Safai S, Momoh M, Koroma V, Kamara FK, Konowu E, Yillah M, French I, Mustapha I, Kanneh F, Foday M, McCarthy H, Kallon T, Kallon M, Naiebu J, Sellu J, Jalloh AA, Gbakie M, Kanneh L, Massaly JL, Kargbo D, Kargbo B, Vandi M, Gbetuwa M, Gevao SM, Sandi JD, Jalloh SC, Grant DS, Blyden SO, Crozier I, Schieffelin JS, McLellan SL, Jacob ST, Boisen ML, Hartnett JN, Cross RW, Branco LM, Andersen KG, Yozwiak NL, Gire SK, Tariyal R, Park DJ, Haislip AM, Bishop CM, Melnik LI, Gallaher WR, Wimley WC, He J, Shaffer JG, Sullivan BM, Grillo S, Oman S, Garry CE, Edwards DR, McCormick SJ, Elliott DH, Rouelle JA, Kannadka CB, Reyna AA, Bradley BT, Yu H, Yenni RE, Hastie KM, Geisbert JB, Kulakosky PC, Wilson RB, Oldstone MB, Pitts KR, Henderson LA, Robinson JE, Geisbert TW, Saphire EO, Happi CT, Asogun DA, Sabeti PC, Garry RF; Viral Hemorrhagic Fever Consortium.

J Infect Dis. 2016 Oct 15;214(suppl 3):S110-S121. Epub 2016 Jul 11.

5.

Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV.

Hastie KM, Igonet S, Sullivan BM, Legrand P, Zandonatti MA, Robinson JE, Garry RF, Rey FA, Oldstone MB, Saphire EO.

Nat Struct Mol Biol. 2016 Jun;23(6):513-521. doi: 10.1038/nsmb.3210. Epub 2016 Apr 25.

6.
7.

Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection.

Ng CT, Sullivan BM, Teijaro JR, Lee AM, Welch M, Rice S, Sheehan KC, Schreiber RD, Oldstone MB.

Cell Host Microbe. 2015 May 13;17(5):653-61. doi: 10.1016/j.chom.2015.04.005.

8.

IgE-activated basophils regulate eosinophil tissue entry by modulating endothelial function.

Cheng LE, Sullivan BM, Retana LE, Allen CD, Liang HE, Locksley RM.

J Exp Med. 2015 Apr 6;212(4):513-24. doi: 10.1084/jem.20141671. Epub 2015 Mar 16.

9.

Early virus-host interactions dictate the course of a persistent infection.

Sullivan BM, Teijaro JR, de la Torre JC, Oldstone MB.

PLoS Pathog. 2015 Jan 8;11(1):e1004588. doi: 10.1371/journal.ppat.1004588. eCollection 2015 Jan.

10.
11.

Type I interferon is a therapeutic target for virus-induced lethal vascular damage.

Baccala R, Welch MJ, Gonzalez-Quintial R, Walsh KB, Teijaro JR, Nguyen A, Ng CT, Sullivan BM, Zarpellon A, Ruggeri ZM, de la Torre JC, Theofilopoulos AN, Oldstone MB.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8925-30. doi: 10.1073/pnas.1408148111. Epub 2014 Jun 2.

12.

Persistent LCMV infection is controlled by blockade of type I interferon signaling.

Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB.

Science. 2013 Apr 12;340(6129):207-11. doi: 10.1126/science.1235214.

13.

Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?

Sullivan BM, Welch MJ, Lemke G, Oldstone MB.

J Virol. 2013 Apr;87(7):4071-4. doi: 10.1128/JVI.03268-12. Epub 2013 Jan 16.

14.

Evaluation of the SO(2) and NH(3) gas adsorption properties of CuO/ZnO/Mn(3)O(4) and CuO/ZnO/NiO ternary impregnated activated carbon using combinatorial materials science methods.

Romero JV, Smith JW, Sullivan BM, Macdonald L, Croll LM, Dahn JR.

ACS Comb Sci. 2013 Feb 11;15(2):101-10. doi: 10.1021/co3001132. Epub 2013 Jan 15.

PMID:
23286549
15.

Slc15a4, a gene required for pDC sensing of TLR ligands, is required to control persistent viral infection.

Blasius AL, Krebs P, Sullivan BM, Oldstone MB, Popkin DL.

PLoS Pathog. 2012 Sep;8(9):e1002915. doi: 10.1371/journal.ppat.1002915. Epub 2012 Sep 13.

16.

Fluorescent in vivo detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition.

Yang Z, Sullivan BM, Allen CD.

Immunity. 2012 May 25;36(5):857-72. doi: 10.1016/j.immuni.2012.02.009. Epub 2012 Mar 8.

17.

Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity.

Liang HE, Reinhardt RL, Bando JK, Sullivan BM, Ho IC, Locksley RM.

Nat Immunol. 2011 Dec 4;13(1):58-66. doi: 10.1038/ni.2182.

18.

SO2 and NH3 gas adsorption on a ternary ZnO/CuO/CuCl2 impregnated activated carbon evaluated using combinatorial methods.

Romero JV, Smith JW, Sullivan BM, Croll LM, Dahn JR.

ACS Comb Sci. 2012 Jan 9;14(1):31-7. doi: 10.1021/co200127g. Epub 2011 Dec 13.

PMID:
22126267
19.

Gas adsorption properties of the ternary ZnO/CuO/CuCl(2) impregnated activated carbon system for multigas respirator applications assessed through combinatorial methods and dynamic adsorption studies.

Romero JV, Smith JW, Sullivan BM, Mallay MG, Croll LM, Reynolds JA, Andress C, Simon M, Dahn JR.

ACS Comb Sci. 2011 Nov 14;13(6):639-45. doi: 10.1021/co200121c. Epub 2011 Oct 13.

PMID:
21978099
20.

Deletion of Syk in neutrophils prevents immune complex arthritis.

Elliott ER, Van Ziffle JA, Scapini P, Sullivan BM, Locksley RM, Lowell CA.

J Immunol. 2011 Oct 15;187(8):4319-30. doi: 10.4049/jimmunol.1100341. Epub 2011 Sep 14.

21.

The role of dendritic cells in viral persistence.

Ng CT, Sullivan BM, Oldstone MB.

Curr Opin Virol. 2011 Sep;1(3):160-6. doi: 10.1016/j.coviro.2011.05.006. Review.

22.

Genetic analysis of basophil function in vivo.

Sullivan BM, Liang HE, Bando JK, Wu D, Cheng LE, McKerrow JK, Allen CD, Locksley RM.

Nat Immunol. 2011 Jun;12(6):527-35. doi: 10.1038/ni.2036. Epub 2011 May 8. Erratum in: Nat Immunol. 2011 Jun;12(6):3 p following 535.

23.

Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner.

Popkin DL, Teijaro JR, Sullivan BM, Urata S, Rutschmann S, de la Torre JC, Kunz S, Beutler B, Oldstone M.

Cell Host Microbe. 2011 Mar 17;9(3):212-222. doi: 10.1016/j.chom.2011.02.006.

24.

Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence.

Sullivan BM, Emonet SF, Welch MJ, Lee AM, Campbell KP, de la Torre JC, Oldstone MB.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2969-74. doi: 10.1073/pnas.1019304108. Epub 2011 Jan 26.

25.

Systemically dispersed innate IL-13-expressing cells in type 2 immunity.

Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM.

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11489-94. doi: 10.1073/pnas.1003988107. Epub 2010 Jun 7.

26.

Buddhists' religious and health practices.

Wiist WH, Sullivan BM, St George DM, Wayment HA.

J Relig Health. 2012 Mar;51(1):132-47. doi: 10.1007/s10943-010-9348-5.

PMID:
20336487
27.

The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling.

Sullivan BM, Coscoy L.

J Virol. 2010 Feb;84(3):1265-75. doi: 10.1128/JVI.01775-09. Epub 2009 Nov 18.

28.

IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway.

Kroeger KM, Sullivan BM, Locksley RM.

J Leukoc Biol. 2009 Oct;86(4):769-78. doi: 10.1189/jlb.0708452. Epub 2009 May 18.

29.

Basophils: a nonredundant contributor to host immunity.

Sullivan BM, Locksley RM.

Immunity. 2009 Jan 16;30(1):12-20. doi: 10.1016/j.immuni.2008.12.006. Review.

30.

A web-based survey of the relationship between buddhist religious practices, health, and psychological characteristics: research methods and preliminary results.

Wiist WH, Sullivan BM, Wayment HA, Warren M.

J Relig Health. 2010 Mar;49(1):18-31. doi: 10.1007/s10943-008-9228-4. Epub 2008 Dec 20.

PMID:
19107601
31.

Normal development and activation but altered cytokine production of Fyn-deficient CD4+ T cells.

Mamchak AA, Sullivan BM, Hou B, Lee LM, Gilden JK, Krummel MF, Locksley RM, DeFranco AL.

J Immunol. 2008 Oct 15;181(8):5374-85.

32.
33.

Regulation of homeostatic chemokine expression and cell trafficking during immune responses.

Mueller SN, Hosiawa-Meagher KA, Konieczny BT, Sullivan BM, Bachmann MF, Locksley RM, Ahmed R, Matloubian M.

Science. 2007 Aug 3;317(5838):670-4.

34.

Neutrophil histamine contributes to inflammation in mycoplasma pneumonia.

Xu X, Zhang D, Zhang H, Wolters PJ, Killeen NP, Sullivan BM, Locksley RM, Lowell CA, Caughey GH.

J Exp Med. 2006 Dec 25;203(13):2907-17. Epub 2006 Dec 11.

35.

Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production.

Sullivan BM, Jobe O, Lazarevic V, Vasquez K, Bronson R, Glimcher LH, Kramnik I.

J Immunol. 2005 Oct 1;175(7):4593-602.

36.

T-bet is required for optimal proinflammatory CD4+ T-cell trafficking.

Lord GM, Rao RM, Choe H, Sullivan BM, Lichtman AH, Luscinskas FW, Glimcher LH.

Blood. 2005 Nov 15;106(10):3432-9. Epub 2005 Jul 12.

37.

Recent developments in the transcriptional regulation of cytolytic effector cells.

Glimcher LH, Townsend MJ, Sullivan BM, Lord GM.

Nat Rev Immunol. 2004 Nov;4(11):900-11. Review.

PMID:
15516969
38.

Combinatorial augmentation for a multi-pathogen biosensor: signal analysis and design.

Moats RK, Sullivan BM.

Biosens Bioelectron. 2004 Jul 15;19(12):1673-83.

PMID:
15142602
39.

Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

Jacobson JM, Israel RJ, Lowy I, Ostrow NA, Vassilatos LS, Barish M, Tran DN, Sullivan BM, Ketas TJ, O'Neill TJ, Nagashima KA, Huang W, Petropoulos CJ, Moore JP, Maddon PJ, Olson WC.

Antimicrob Agents Chemother. 2004 Feb;48(2):423-9.

40.

Antigen-driven effector CD8 T cell function regulated by T-bet.

Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15818-23. Epub 2003 Dec 12.

41.

Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells.

Ketas TJ, Frank I, Klasse PJ, Sullivan BM, Gardner JP, Spenlehauer C, Nesin M, Olson WC, Moore JP, Pope M.

J Virol. 2003 Feb;77(4):2762-7.

42.

Molecular mechanisms regulating Th1 immune responses.

Szabo SJ, Sullivan BM, Peng SL, Glimcher LH.

Annu Rev Immunol. 2003;21:713-58. Epub 2001 Dec 19. Review.

PMID:
12500979
43.

The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.

Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR, Bhan A, Autschbach F, Sullivan BM, Szabo SJ, Glimcher LH, Blumberg RS.

J Exp Med. 2002 May 6;195(9):1129-43. Erratum in: J Exp Med 2002 Jun 3;195(11):1513.

44.

Summary of recent NASA studies of human response to sonic booms.

Leatherwood JD, Sullivan BM, Shepherd KP, McCurdy DA, Brown SA.

J Acoust Soc Am. 2002 Jan;111(1 Pt 2):586-98.

PMID:
11837964
45.

Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH.

Science. 2002 Jan 11;295(5553):338-42.

46.

Polycystin-1 interacts with intermediate filaments.

Xu GM, Sikaneta T, Sullivan BM, Zhang Q, Andreucci M, Stehle T, Drummond I, Arnaout MA.

J Biol Chem. 2001 Dec 7;276(49):46544-52. Epub 2001 Oct 1.

47.

The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.

Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM.

Virology. 2001 May 10;283(2):230-9.

48.

RGS4 and RGS2 bind coatomer and inhibit COPI association with Golgi membranes and intracellular transport.

Sullivan BM, Harrison-Lavoie KJ, Marshansky V, Lin HY, Kehrl JH, Ausiello DA, Brown D, Druey KM.

Mol Biol Cell. 2000 Sep;11(9):3155-68.

49.

Expression of GTPase-deficient Gialpha2 results in translocation of cytoplasmic RGS4 to the plasma membrane.

Druey KM, Sullivan BM, Brown D, Fischer ER, Watson N, Blumer KJ, Gerfen CR, Scheschonka A, Kehrl JH.

J Biol Chem. 1998 Jul 17;273(29):18405-10.

50.

Localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase to the trans-Golgi network.

Humphries DE, Sullivan BM, Aleixo MD, Stow JL.

Biochem J. 1997 Jul 15;325 ( Pt 2):351-7.

Supplemental Content

Loading ...
Support Center